Tag Dolutegravir

WHO Issues Guideline On Use Of New HIV Treatment Drug For Pregnant Women

The World Health Organization, WHO has issued an updated recommendation on the use of new antiretroviral therapy by expectant women, stating that the risk of neural tube defects was minimal using Dolutegravir, (DTG) . The safety of dolutegravir (DTG), during

Continue reading…

Breakthrough As WHO Certifies New HIV Treatment Drug For Pregnant Women

An antiretroviral drug Dolutegravir, commonly known as DTG, has been certified safe for use by pregnant women and those in their reproductive years by the World Health Organisation (WHO). Though initial research linked the drug with neural tube defects (NTDs)

Continue reading…